1
|
Kvastad L, Carlberg K, Larsson L, Villacampa EG, Stuckey A, Stenbeck L, Mollbrink A, Zamboni M, Magnusson JP, Basmaci E, Shamikh A, Prochazka G, Schaupp AL, Borg Å, Fugger L, Nistér M, Lundeberg J. The spatial RNA integrity number assay for in situ evaluation of transcriptome quality. Commun Biol 2021; 4:57. [PMID: 33420318 PMCID: PMC7794352 DOI: 10.1038/s42003-020-01573-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Accepted: 11/11/2020] [Indexed: 12/03/2022] Open
Abstract
The RNA integrity number (RIN) is a frequently used quality metric to assess the completeness of rRNA, as a proxy for the corresponding mRNA in a tissue. Current methods operate at bulk resolution and provide a single average estimate for the whole sample. Spatial transcriptomics technologies have emerged and shown their value by placing gene expression into a tissue context, resulting in transcriptional information from all tissue regions. Thus, the ability to estimate RNA quality in situ has become of utmost importance to overcome the limitation with a bulk rRNA measurement. Here we show a new tool, the spatial RNA integrity number (sRIN) assay, to assess the rRNA completeness in a tissue wide manner at cellular resolution. We demonstrate the use of sRIN to identify spatial variation in tissue quality prior to more comprehensive spatial transcriptomics workflows.
Collapse
Affiliation(s)
- Linda Kvastad
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Konstantin Carlberg
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Ludvig Larsson
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Eva Gracia Villacampa
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Alexander Stuckey
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Linnea Stenbeck
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Annelie Mollbrink
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden
| | - Margherita Zamboni
- Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
| | - Jens Peter Magnusson
- Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
- Bioengineering Department, Stanford University, Stanford, USA
| | - Elisa Basmaci
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
| | - Alia Shamikh
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
| | - Gabriela Prochazka
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
| | - Anna-Lena Schaupp
- Nuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK
| | - Åke Borg
- Division of Oncology and Pathology, Department of Clinical Sciences, Lund Lund University, Lund, Sweden
| | - Lars Fugger
- Nuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK
| | - Monica Nistér
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
| | - Joakim Lundeberg
- Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.
| |
Collapse
|